Nasal Mucociliary Clearance in Subjects With COPD After Smoking Cessation

Exposure to cigarette smoke causes significant impairment in mucociliary clearance (MCC), which predisposes patients to secretion retention and recurrent airway infections that play a role in exacerbations of COPD. To determine whether smoking cessation may influence MCC and frequency of exacerbatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory care 2015-03, Vol.60 (3), p.399-405
Hauptverfasser: Ito, Juliana T, Ramos, Dionei, Lima, Fabiano F, Rodrigues, Fernanda M M, Gomes, Paulo R, Moreira, Graciane L, Macchione, Mariangela, Toledo, Alessandra C, Ramos, Ercy M C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 405
container_issue 3
container_start_page 399
container_title Respiratory care
container_volume 60
creator Ito, Juliana T
Ramos, Dionei
Lima, Fabiano F
Rodrigues, Fernanda M M
Gomes, Paulo R
Moreira, Graciane L
Macchione, Mariangela
Toledo, Alessandra C
Ramos, Ercy M C
description Exposure to cigarette smoke causes significant impairment in mucociliary clearance (MCC), which predisposes patients to secretion retention and recurrent airway infections that play a role in exacerbations of COPD. To determine whether smoking cessation may influence MCC and frequency of exacerbations, the following groups were evaluated: ex-smokers with COPD, smokers with COPD, current smokers with normal lung function, and nonsmokers with normal lung function. Ninety-three subjects were divided into 4 groups: ex-smokers with COPD (n = 23, 62.4 ± 8.0 y, 13 males), smokers with COPD (n = 17, 58.2 ± 8.0 y, 6 males), current smokers (n = 27, 61.5 ± 6.4 y, 17 males), and nonsmokers (n = 26, 60.8 ± 11.3 y, 7 males). MCC was evaluated using the saccharin transit time (STT) test, and the frequency of exacerbations in the last year was assessed by questionnaire. The Kruskal-Wallis test followed by Dunn's test were used to compare STT among groups, and the Goodman test was used to compare the frequency of exacerbations. STT of smokers with COPD (16.5 [11-28] min; median [interquartile range 25-75%]) and current smokers (15.9 [10-27] min) was longer compared with ex-smokers with COPD (9.7 [6-12] min) and nonsmokers (8 [6-16] min) (P < .001). There was no difference in STT values between smokers with COPD and current smokers, and these values in ex-smokers with COPD were similar to the control group (P > .05). The frequency of exacerbations was lower in ex-smokers with COPD compared with smokers with COPD. One year after smoking cessation, subjects with COPD had improved mucociliary clearance.
doi_str_mv 10.4187/respcare.03266
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1660927744</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A404754857</galeid><sourcerecordid>A404754857</sourcerecordid><originalsourceid>FETCH-LOGICAL-c433t-b4b78e4f72b57e7fc48863c5f8e6c88229828bf0f34f77f3a1c15a4fbdca56243</originalsourceid><addsrcrecordid>eNptkc1r3DAQxUVoSDZJrz0WQaHk4q2sbx8Xt2kDSRNIS49C1o6ySmVrK9mH_Pf1Nh-kEOYwzPB7A_MeQu9qsuS1Vp8ylK2zGZaEUSn30KJuOKuYFPwNWhBCSVUzyg_RUSl38yi5aA7QIRVMN0zQBTr_bouN-HJyyYUYbL7HbQSb7eAAhwHfTN0duLHgX2Hc4Pbq-jNe-REyvunT7zDc4hZKsWNIwwna9zYWePvYj9HPsy8_2m_VxdXX83Z1UTnO2Fh1vFMauFe0EwqUd1xryZzwGqTTmtJGU9154tnMKM9s7Wphue_WzgpJOTtGpw93tzn9maCMpg_FQYx2gDQVU0tJGqoU36EfHtBbG8GEwacxW7fDzYoTrgTXQs3U8hVqrjX0waUBfJj3_wk-vhBswMZxU1Kcdi6UVy-7nErJ4M02h3722NTE7OIzT_GZf_HNgvePv01dD-tn_Ckv9hdV2pR_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1660927744</pqid></control><display><type>article</type><title>Nasal Mucociliary Clearance in Subjects With COPD After Smoking Cessation</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Ito, Juliana T ; Ramos, Dionei ; Lima, Fabiano F ; Rodrigues, Fernanda M M ; Gomes, Paulo R ; Moreira, Graciane L ; Macchione, Mariangela ; Toledo, Alessandra C ; Ramos, Ercy M C</creator><creatorcontrib>Ito, Juliana T ; Ramos, Dionei ; Lima, Fabiano F ; Rodrigues, Fernanda M M ; Gomes, Paulo R ; Moreira, Graciane L ; Macchione, Mariangela ; Toledo, Alessandra C ; Ramos, Ercy M C</creatorcontrib><description>Exposure to cigarette smoke causes significant impairment in mucociliary clearance (MCC), which predisposes patients to secretion retention and recurrent airway infections that play a role in exacerbations of COPD. To determine whether smoking cessation may influence MCC and frequency of exacerbations, the following groups were evaluated: ex-smokers with COPD, smokers with COPD, current smokers with normal lung function, and nonsmokers with normal lung function. Ninety-three subjects were divided into 4 groups: ex-smokers with COPD (n = 23, 62.4 ± 8.0 y, 13 males), smokers with COPD (n = 17, 58.2 ± 8.0 y, 6 males), current smokers (n = 27, 61.5 ± 6.4 y, 17 males), and nonsmokers (n = 26, 60.8 ± 11.3 y, 7 males). MCC was evaluated using the saccharin transit time (STT) test, and the frequency of exacerbations in the last year was assessed by questionnaire. The Kruskal-Wallis test followed by Dunn's test were used to compare STT among groups, and the Goodman test was used to compare the frequency of exacerbations. STT of smokers with COPD (16.5 [11-28] min; median [interquartile range 25-75%]) and current smokers (15.9 [10-27] min) was longer compared with ex-smokers with COPD (9.7 [6-12] min) and nonsmokers (8 [6-16] min) (P &lt; .001). There was no difference in STT values between smokers with COPD and current smokers, and these values in ex-smokers with COPD were similar to the control group (P &gt; .05). The frequency of exacerbations was lower in ex-smokers with COPD compared with smokers with COPD. One year after smoking cessation, subjects with COPD had improved mucociliary clearance.</description><identifier>ISSN: 0020-1324</identifier><identifier>EISSN: 1943-3654</identifier><identifier>DOI: 10.4187/respcare.03266</identifier><identifier>PMID: 25389352</identifier><language>eng</language><publisher>United States: Daedalus Enterprises, Inc</publisher><subject>Aged ; Aged, 80 and over ; Development and progression ; Disease Progression ; Female ; Health aspects ; Humans ; Lung diseases, Obstructive ; Male ; Middle Aged ; Mucociliary Clearance - physiology ; Mucociliary system ; Nose - metabolism ; Pulmonary Disease, Chronic Obstructive - metabolism ; Pulmonary Disease, Chronic Obstructive - physiopathology ; Pulmonary Disease, Chronic Obstructive - rehabilitation ; Smoking - adverse effects ; Smoking Cessation ; Smoking cessation programs ; Time Factors</subject><ispartof>Respiratory care, 2015-03, Vol.60 (3), p.399-405</ispartof><rights>Copyright © 2015 by Daedalus Enterprises.</rights><rights>COPYRIGHT 2015 Daedalus Enterprises, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c433t-b4b78e4f72b57e7fc48863c5f8e6c88229828bf0f34f77f3a1c15a4fbdca56243</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25389352$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ito, Juliana T</creatorcontrib><creatorcontrib>Ramos, Dionei</creatorcontrib><creatorcontrib>Lima, Fabiano F</creatorcontrib><creatorcontrib>Rodrigues, Fernanda M M</creatorcontrib><creatorcontrib>Gomes, Paulo R</creatorcontrib><creatorcontrib>Moreira, Graciane L</creatorcontrib><creatorcontrib>Macchione, Mariangela</creatorcontrib><creatorcontrib>Toledo, Alessandra C</creatorcontrib><creatorcontrib>Ramos, Ercy M C</creatorcontrib><title>Nasal Mucociliary Clearance in Subjects With COPD After Smoking Cessation</title><title>Respiratory care</title><addtitle>Respir Care</addtitle><description>Exposure to cigarette smoke causes significant impairment in mucociliary clearance (MCC), which predisposes patients to secretion retention and recurrent airway infections that play a role in exacerbations of COPD. To determine whether smoking cessation may influence MCC and frequency of exacerbations, the following groups were evaluated: ex-smokers with COPD, smokers with COPD, current smokers with normal lung function, and nonsmokers with normal lung function. Ninety-three subjects were divided into 4 groups: ex-smokers with COPD (n = 23, 62.4 ± 8.0 y, 13 males), smokers with COPD (n = 17, 58.2 ± 8.0 y, 6 males), current smokers (n = 27, 61.5 ± 6.4 y, 17 males), and nonsmokers (n = 26, 60.8 ± 11.3 y, 7 males). MCC was evaluated using the saccharin transit time (STT) test, and the frequency of exacerbations in the last year was assessed by questionnaire. The Kruskal-Wallis test followed by Dunn's test were used to compare STT among groups, and the Goodman test was used to compare the frequency of exacerbations. STT of smokers with COPD (16.5 [11-28] min; median [interquartile range 25-75%]) and current smokers (15.9 [10-27] min) was longer compared with ex-smokers with COPD (9.7 [6-12] min) and nonsmokers (8 [6-16] min) (P &lt; .001). There was no difference in STT values between smokers with COPD and current smokers, and these values in ex-smokers with COPD were similar to the control group (P &gt; .05). The frequency of exacerbations was lower in ex-smokers with COPD compared with smokers with COPD. One year after smoking cessation, subjects with COPD had improved mucociliary clearance.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Development and progression</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Lung diseases, Obstructive</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mucociliary Clearance - physiology</subject><subject>Mucociliary system</subject><subject>Nose - metabolism</subject><subject>Pulmonary Disease, Chronic Obstructive - metabolism</subject><subject>Pulmonary Disease, Chronic Obstructive - physiopathology</subject><subject>Pulmonary Disease, Chronic Obstructive - rehabilitation</subject><subject>Smoking - adverse effects</subject><subject>Smoking Cessation</subject><subject>Smoking cessation programs</subject><subject>Time Factors</subject><issn>0020-1324</issn><issn>1943-3654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkc1r3DAQxUVoSDZJrz0WQaHk4q2sbx8Xt2kDSRNIS49C1o6ySmVrK9mH_Pf1Nh-kEOYwzPB7A_MeQu9qsuS1Vp8ylK2zGZaEUSn30KJuOKuYFPwNWhBCSVUzyg_RUSl38yi5aA7QIRVMN0zQBTr_bouN-HJyyYUYbL7HbQSb7eAAhwHfTN0duLHgX2Hc4Pbq-jNe-REyvunT7zDc4hZKsWNIwwna9zYWePvYj9HPsy8_2m_VxdXX83Z1UTnO2Fh1vFMauFe0EwqUd1xryZzwGqTTmtJGU9154tnMKM9s7Wphue_WzgpJOTtGpw93tzn9maCMpg_FQYx2gDQVU0tJGqoU36EfHtBbG8GEwacxW7fDzYoTrgTXQs3U8hVqrjX0waUBfJj3_wk-vhBswMZxU1Kcdi6UVy-7nErJ4M02h3722NTE7OIzT_GZf_HNgvePv01dD-tn_Ckv9hdV2pR_</recordid><startdate>201503</startdate><enddate>201503</enddate><creator>Ito, Juliana T</creator><creator>Ramos, Dionei</creator><creator>Lima, Fabiano F</creator><creator>Rodrigues, Fernanda M M</creator><creator>Gomes, Paulo R</creator><creator>Moreira, Graciane L</creator><creator>Macchione, Mariangela</creator><creator>Toledo, Alessandra C</creator><creator>Ramos, Ercy M C</creator><general>Daedalus Enterprises, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201503</creationdate><title>Nasal Mucociliary Clearance in Subjects With COPD After Smoking Cessation</title><author>Ito, Juliana T ; Ramos, Dionei ; Lima, Fabiano F ; Rodrigues, Fernanda M M ; Gomes, Paulo R ; Moreira, Graciane L ; Macchione, Mariangela ; Toledo, Alessandra C ; Ramos, Ercy M C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c433t-b4b78e4f72b57e7fc48863c5f8e6c88229828bf0f34f77f3a1c15a4fbdca56243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Development and progression</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Lung diseases, Obstructive</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mucociliary Clearance - physiology</topic><topic>Mucociliary system</topic><topic>Nose - metabolism</topic><topic>Pulmonary Disease, Chronic Obstructive - metabolism</topic><topic>Pulmonary Disease, Chronic Obstructive - physiopathology</topic><topic>Pulmonary Disease, Chronic Obstructive - rehabilitation</topic><topic>Smoking - adverse effects</topic><topic>Smoking Cessation</topic><topic>Smoking cessation programs</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ito, Juliana T</creatorcontrib><creatorcontrib>Ramos, Dionei</creatorcontrib><creatorcontrib>Lima, Fabiano F</creatorcontrib><creatorcontrib>Rodrigues, Fernanda M M</creatorcontrib><creatorcontrib>Gomes, Paulo R</creatorcontrib><creatorcontrib>Moreira, Graciane L</creatorcontrib><creatorcontrib>Macchione, Mariangela</creatorcontrib><creatorcontrib>Toledo, Alessandra C</creatorcontrib><creatorcontrib>Ramos, Ercy M C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Respiratory care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ito, Juliana T</au><au>Ramos, Dionei</au><au>Lima, Fabiano F</au><au>Rodrigues, Fernanda M M</au><au>Gomes, Paulo R</au><au>Moreira, Graciane L</au><au>Macchione, Mariangela</au><au>Toledo, Alessandra C</au><au>Ramos, Ercy M C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nasal Mucociliary Clearance in Subjects With COPD After Smoking Cessation</atitle><jtitle>Respiratory care</jtitle><addtitle>Respir Care</addtitle><date>2015-03</date><risdate>2015</risdate><volume>60</volume><issue>3</issue><spage>399</spage><epage>405</epage><pages>399-405</pages><issn>0020-1324</issn><eissn>1943-3654</eissn><abstract>Exposure to cigarette smoke causes significant impairment in mucociliary clearance (MCC), which predisposes patients to secretion retention and recurrent airway infections that play a role in exacerbations of COPD. To determine whether smoking cessation may influence MCC and frequency of exacerbations, the following groups were evaluated: ex-smokers with COPD, smokers with COPD, current smokers with normal lung function, and nonsmokers with normal lung function. Ninety-three subjects were divided into 4 groups: ex-smokers with COPD (n = 23, 62.4 ± 8.0 y, 13 males), smokers with COPD (n = 17, 58.2 ± 8.0 y, 6 males), current smokers (n = 27, 61.5 ± 6.4 y, 17 males), and nonsmokers (n = 26, 60.8 ± 11.3 y, 7 males). MCC was evaluated using the saccharin transit time (STT) test, and the frequency of exacerbations in the last year was assessed by questionnaire. The Kruskal-Wallis test followed by Dunn's test were used to compare STT among groups, and the Goodman test was used to compare the frequency of exacerbations. STT of smokers with COPD (16.5 [11-28] min; median [interquartile range 25-75%]) and current smokers (15.9 [10-27] min) was longer compared with ex-smokers with COPD (9.7 [6-12] min) and nonsmokers (8 [6-16] min) (P &lt; .001). There was no difference in STT values between smokers with COPD and current smokers, and these values in ex-smokers with COPD were similar to the control group (P &gt; .05). The frequency of exacerbations was lower in ex-smokers with COPD compared with smokers with COPD. One year after smoking cessation, subjects with COPD had improved mucociliary clearance.</abstract><cop>United States</cop><pub>Daedalus Enterprises, Inc</pub><pmid>25389352</pmid><doi>10.4187/respcare.03266</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0020-1324
ispartof Respiratory care, 2015-03, Vol.60 (3), p.399-405
issn 0020-1324
1943-3654
language eng
recordid cdi_proquest_miscellaneous_1660927744
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Aged
Aged, 80 and over
Development and progression
Disease Progression
Female
Health aspects
Humans
Lung diseases, Obstructive
Male
Middle Aged
Mucociliary Clearance - physiology
Mucociliary system
Nose - metabolism
Pulmonary Disease, Chronic Obstructive - metabolism
Pulmonary Disease, Chronic Obstructive - physiopathology
Pulmonary Disease, Chronic Obstructive - rehabilitation
Smoking - adverse effects
Smoking Cessation
Smoking cessation programs
Time Factors
title Nasal Mucociliary Clearance in Subjects With COPD After Smoking Cessation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T01%3A25%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nasal%20Mucociliary%20Clearance%20in%20Subjects%20With%20COPD%20After%20Smoking%20Cessation&rft.jtitle=Respiratory%20care&rft.au=Ito,%20Juliana%20T&rft.date=2015-03&rft.volume=60&rft.issue=3&rft.spage=399&rft.epage=405&rft.pages=399-405&rft.issn=0020-1324&rft.eissn=1943-3654&rft_id=info:doi/10.4187/respcare.03266&rft_dat=%3Cgale_proqu%3EA404754857%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1660927744&rft_id=info:pmid/25389352&rft_galeid=A404754857&rfr_iscdi=true